Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olga Pitsillidou

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Pharmacoeconomics - Open|April 4, 2024
Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in CyprusOlga Pitsillidou, Panagiotis Petrou, M J Postma
Journal of Medical Economics|February 9, 2022
The notion of Surrogacy in Health Technology Assessment: an insight in the processes of Germany, UK and FrancePanagiotis Petrou, Olga Pitsillidou, M J Postma
Expert Review of Pharmacoeconomics & Outcomes Research|July 23, 2023
Implementing a Managed Entry Agreement Framework in CyprusOlga Pitsillidou, Panagiotis Petrou, M J Postma
Journal of Medical Economics|March 16, 2026
Cost per event avoided: adopt or avoid?P Petrou, Olga Pitsillidou, Constantinos Petrou, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Pharmacoeconomics - Open|April 4, 2024
Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in CyprusOlga Pitsillidou, Panagiotis Petrou, M J Postma
Journal of Medical Economics|February 9, 2022
The notion of Surrogacy in Health Technology Assessment: an insight in the processes of Germany, UK and FrancePanagiotis Petrou, Olga Pitsillidou, M J Postma
Expert Review of Pharmacoeconomics & Outcomes Research|July 23, 2023
Implementing a Managed Entry Agreement Framework in CyprusOlga Pitsillidou, Panagiotis Petrou, M J Postma
Journal of Medical Economics|March 16, 2026
Cost per event avoided: adopt or avoid?P Petrou, Olga Pitsillidou, Constantinos Petrou, et al.
Pageof 1